Assura Plc (LON:AGR) Insider Buys £149.64 in Stock

Assura Plc (LON:AGRGet Free Report) insider Jayne Cottam acquired 348 shares of Assura stock in a transaction on Monday, April 7th. The shares were purchased at an average price of GBX 43 ($0.56) per share, for a total transaction of £149.64 ($194.24).

Jayne Cottam also recently made the following trade(s):

  • On Wednesday, March 5th, Jayne Cottam bought 363 shares of Assura stock. The stock was purchased at an average price of GBX 41 ($0.53) per share, with a total value of £148.83 ($193.19).
  • On Wednesday, February 5th, Jayne Cottam purchased 405 shares of Assura stock. The shares were purchased at an average price of GBX 37 ($0.48) per share, for a total transaction of £149.85 ($194.51).

Assura Stock Up 0.3 %

Shares of Assura stock opened at GBX 47.66 ($0.62) on Friday. The company has a debt-to-equity ratio of 85.05, a current ratio of 0.89 and a quick ratio of 2.84. The stock has a market cap of £1.55 billion, a price-to-earnings ratio of -45.56, a PEG ratio of 3.60 and a beta of 0.37. The firm’s 50-day moving average is GBX 43.64 and its two-hundred day moving average is GBX 40.67. Assura Plc has a 1 year low of GBX 35.24 ($0.46) and a 1 year high of GBX 48.86 ($0.63).

About Assura

(Get Free Report)

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.

Further Reading

Insider Buying and Selling by Quarter for Assura (LON:AGR)

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.